Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

Individualizing treatment assignment can improve outcomes for diseases with patient-to-patient variability in comparative treatment effects. When a clinical trial demonstrates that some patients improve on treatment while others do not, it is tempting to assume that treatment effect heterogeneity exists. However, if outcome variability is mainly driven by factors other than variability in the treatment effect, investigating the extent to which covariate data can predict differential treatment response is a potential waste of resources. Motivated by recent meta-analyses assessing the potential of individualizing treatment for major depressive disorder using only summary statistics, we provide a method that uses summary statistics widely available in published clinical trial results to bound the benefit of optimally assigning treatment to each patient. We also offer alternate bounds for settings in which trial results are stratified by another covariate. Our upper bounds can be especially informative when they are small, as there is then little benefit to collecting additional covariate data. We demonstrate our approach using summary statistics from a depression treatment trial. Our methods are implemented in the rct2otrbounds R package, which is available at https://github.com/ngalanter/rct2otrbounds.

Ranking tailoring variables for constructing individualized treatment rules: an application to schizophrenia.

As with many chronic conditions, matching patients with schizophrenia to the best treatment options is difficult. Selecting antipsychotic medication is especially challenging because many of the medications can have burdensome side effects. Adjusting or tailoring medications based on patients' characteristics could improve symptoms. However, it is often not known which patient characteristics are most helpful for informing treatment selection. In this paper, we address the challenge of identifying and ranking important variables for tailoring treatment decisions. We consider a value-search approach implemented through dynamic marginal structural models to estimate an optimal individualized treatment rule. We apply our methodology to the Clinical Antipsychotics Trial of Intervention and Effectiveness (CATIE) study for schizophrenia, to evaluate if some tailoring variables have greater potential than others for selecting treatments for patients with schizophrenia (Stroup et al., 2003).

Resource competition amid overlapping territories: The territorial raider model applied to multi-group interactions.

Many organisms maintain collective territories and compete on behalf of the fitness of the overall group. Inspired by this concept, the territorial raider model is a graph-based resource competition in which populations have fixed home locations and a limited range of sites accessible for raiding. In our present extension of the model, groups control "colonies" or "armies" which can be divided across multiple locations. We present Nash equilibria for games played on both regular graphs and regular bipartite graphs, and we also examine differences that emerge when populations are composed of discrete units (pack scale) or when they are continuously divisible (colony scale). Reliance upon defense over aggressive raiding is greater here than in the original model where populations had to totally commit to a singular action. This defensive posture increases with the advantage of the local population and also varies with the degree of the graph's connectivity. When discrete units are employed, multiple strategies emerge.